Universal Ibogaine Inc (IBO) Financial Statements
Universal Ibogaine Inc Financial Overview
Universal Ibogaine Inc's market cap is currently $1.37M. The company's EPS TTM is $-0.00; its P/E ratio is -0.50; Universal Ibogaine Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jan 25 | Jul 23 | Oct 22 | Jul 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.33M | $ 1.03M | $ 1.07M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 2.33M | $ 1.03M | $ 1.07M | $ 0.00 | $ 0.00 |
| Operating Income | $ 551.66K | $ -28.03K | $ 497.15K | $ -3.83M | $ 383.00 |
| EBITDA | $ -1.54M | $ -1.98M | $ -4.61M | $ -3.76M | $ 638.00 |
| Net Income | $ -2.05M | $ -2.39M | $ -10.50M | $ -3.87M | $ -118.31K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 370.80K | $ 313.26K | $ 726.05K | $ 142.20K | $ 72.50K |
| Total Assets | $ 4.51M | $ 5.50M | $ 6.32M | $ 3.99M | $ 116.61K |
| Total Debt | $ 2.65M | $ 2.78M | $ 1.74M | $ 410.00K | $ 0.00 |
| Net Debt | $ 2.28M | $ 2.46M | $ 1.01M | $ 267.80K | $ -72.50K |
| Total Liabilities | $ 3.52M | $ 3.75M | $ 2.37M | $ 1.05M | $ 21.72K |
| Stockholders' Equity | $ 991.11K | $ 1.75M | $ 3.94M | $ 2.94M | $ 94.89K |
| Cash Flow | |||||
| Free Cash Flow | $ -917.17K | $ -1.46M | $ -4.43M | $ -3.25M | $ -123.51K |
| Operating Cash Flow | $ -838.61K | $ -1.10M | $ -4.33M | $ -3.25M | $ -121.98K |
| Investing Cash Flow | $ -78.56K | $ -360.04K | $ -2.09M | $ -42.93K | $ -26.53K |
| Financing Cash Flow | $ 974.70K | $ 1.04M | $ 7.01M | $ 3.38M | $ 16.09K |
Currency in CAD